dexamethasone

FDA Drug Profile — Hemady, dexamethasone, Dexamethasone, MAXIDEX, Dexycu

dexamethasone is listed in the FDA National Drug Code directory with 24 NDC codes, marketed under brand names including Hemady, dexamethasone, Dexamethasone. Available dosage forms: tablet, powder, for suspension, injection, suspension, implant.

Drug Details

Generic Name
dexamethasone
Brand Names
Hemady, dexamethasone, Dexamethasone, MAXIDEX, Dexycu, OZURDEX, DEXTENZA
Application Number
NDA211379
Sponsor
Edenbridge Pharmaceuticals LLC.
NDC Codes
24
Dosage Forms
TABLET, POWDER, FOR SUSPENSION, INJECTION, SUSPENSION, IMPLANT, INSERT
Routes
ORAL, OPHTHALMIC, INTRAOCULAR, INTRAVITREAL, INTRACANALICULAR
Active Ingredients
DEXAMETHASONE

Indications and Usage

1 INDICATIONS AND USAGE OZURDEX is a corticosteroid indicated for: The treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO) ( 1.1 ) The treatment of non-infectious uveitis affecting the posterior segment of the eye ( 1.2 ) The treatment of diabetic macular edema ( 1.3 ) 1.1 Retinal Vein Occlusion OZURDEX ® (dexamethasone intravitreal implant) is indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO). 1.2 Posterior Segment Uveitis OZURDEX is indicated for the treatment of non-infectious uveitis affecting the posterior segment of the eye. 1.3 Diabetic Macular Edema OZURDEX is indicated for the treatment of diabetic macular edema.